Suggestions
Damiano Rondelli
Michael Reese Professor of Hematology Chief, Division of Hematology/Oncology, Director of BMT; Associate Director for Global Partnerships, Center for Global Health, College of Medicine - University of Illinois at Chicago
Dr. Damiano Rondelli is a prominent figure in the field of hematology and oncology, currently serving as the Michael Reese Professor of Hematology at the University of Illinois at Chicago (UIC). He holds multiple leadership roles, including Chief of the Division of Hematology/Oncology and Director of Blood and Marrow Transplantation (BMT). His expertise lies primarily in stem cell transplantation, particularly for patients with hematologic malignancies such as leukemia, lymphoma, myeloma, and sickle cell anemia.124
Education and Career Background
Dr. Rondelli received his medical degree from the University of Bologna in Italy, where he also completed his fellowship training. He further advanced his research skills at the Fred Hutchinson Cancer Research Center in Seattle, focusing on the immunology of stem cell transplantation. He joined UIC in 2002 as Director of the Blood and Marrow Transplant Program and became Chief of the Division of Hematology/Oncology in 2013.35
Research Contributions
His research encompasses both clinical and laboratory studies aimed at improving outcomes for high-risk patients undergoing allogeneic stem cell transplants. Notably, he has been involved in pioneering work that has led to successful treatments for patients with complex conditions like sickle cell disease.124 Dr. Rondelli has authored over 100 peer-reviewed articles and book chapters, contributing significantly to the scientific community's understanding of hematologic disorders.24
Global Impact
In addition to his clinical roles, Dr. Rondelli is the Associate Director for Global Partnerships at UIC's Center for Global Health, indicating his commitment to expanding healthcare access and research on a global scale.16
Dr. Rondelli's extensive experience and ongoing contributions to hematology make him a key figure in advancing treatment options for patients with serious blood disorders.